-
公开(公告)号:LU91237I2
公开(公告)日:2007-02-22
申请号:LU91237
申请日:2006-04-24
Applicant: RUBIN JEFFREY S , FINCH PAUL W , AARONSON STUART A
IPC: A61K39/395 , A61K38/00 , A61K38/18 , A61K38/22 , A61P17/02 , A61P43/00 , C07H21/04 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/47 , C07K14/475 , C07K14/485 , C07K14/50 , C07K16/00 , C07K16/22 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/08 , C12N5/10 , C12N15/09 , C12N15/12 , C12N15/18 , C12N15/63 , C12N15/70 , C12N15/79 , C12P21/00 , C12P21/02 , C12Q1/68 , C12Q1/6876 , C12R1/91 , G01N33/48 , G01N33/50 , G01N33/53
-
公开(公告)号:DE60027431D1
公开(公告)日:2006-05-24
申请号:DE60027431
申请日:2000-06-30
Applicant: LIPTON STUART A
Inventor: LIPTON STUART A
IPC: A61K31/40 , C07D401/04 , A61K31/00 , A61K31/415 , A61K31/424 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K45/00 , A61P3/08 , A61P3/10 , A61P9/10 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P27/06 , A61P39/02 , A61P43/00 , C07D401/14 , C07D413/04 , C07D471/04 , C07D513/04
Abstract: The invention relates to a method of reducing neuronal injury or apoptosis including administering to a patient in need thereof an effective amount of a p38 mitogen-activated protein kinase (MAPK) inhibitor. Methods of treating an HIV-mediated dementia, glaucoma, or other neurodegenerative disorders are also disclosed.
-
公开(公告)号:AT323482T
公开(公告)日:2006-05-15
申请号:AT00948576
申请日:2000-06-30
Applicant: LIPTON STUART A
Inventor: LIPTON STUART A
IPC: C07D401/04 , A61K31/00 , A61K31/424 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K45/00 , A61P3/08 , A61P3/10 , A61P9/10 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P27/06 , A61P39/02 , A61P43/00 , C07D401/14 , C07D413/04 , C07D471/04 , C07D513/04 , A61K31/40 , A61K31/415
Abstract: The invention relates to a method of reducing neuronal injury or apoptosis including administering to a patient in need thereof an effective amount of a p38 mitogen-activated protein kinase (MAPK) inhibitor. Methods of treating an HIV-mediated dementia, glaucoma, or other neurodegenerative disorders are also disclosed.
-
公开(公告)号:AU777275B2
公开(公告)日:2004-10-07
申请号:AU6205200
申请日:2000-06-30
Applicant: LIPTON STUART A
Inventor: LIPTON STUART A
IPC: C07D401/04 , A61K31/00 , A61K31/424 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K45/00 , A61P3/08 , A61P3/10 , A61P9/10 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P27/06 , A61P39/02 , A61P43/00 , C07D401/14 , C07D413/04 , C07D471/04 , C07D513/04 , A61K31/40 , A61K31/415 , A61K31/44
Abstract: The invention relates to a method of reducing neuronal injury or apoptosis including administering to a patient in need thereof an effective amount of a p38 mitogen-activated protein kinase (MAPK) inhibitor. Methods of treating an HIV-mediated dementia, glaucoma, or other neurodegenerative disorders are also disclosed.
-
公开(公告)号:DE69816043D1
公开(公告)日:2003-08-07
申请号:DE69816043
申请日:1998-03-06
Applicant: BUSSE STUART A
Inventor: BUSSE STUART A
-
公开(公告)号:CA2282084A1
公开(公告)日:2001-03-10
申请号:CA2282084
申请日:1999-09-10
Applicant: JACKSON STUART A , HUDDA KARIMA , ATRAZHEVA ELENA , MERCER JOHN R , WANG SANYI
Inventor: JACKSON STUART A , HUDDA KARIMA , ATRAZHEVA ELENA , MERCER JOHN R , WANG SANYI
IPC: G01J1/50
Abstract: A radiation indicator device for use in indicating exposure to ultraviolet -B radiation. The device includes a radiation sensitive mixture which is selectively responsive to ultraviolet radiation having a wavelength substantially within or shorter than the range of wavelengths of ultraviolet-B radiation. The radiation sensitive mixture includes an organic halogen constituent capable of producing at leas t one acidic product upon exposure to ultraviolet radiation and an indicator constituent capable of producing a change in colour in response to a change in concentration of the acidic product. The radiation sensitive mixture has a first colour representing a relatively low concentration of the acidic product and has a second colour representing a relatively high concentration of the acidic product. The first colour is visually distinguishable from the second colour. The device may also include a graphic pattern interposed amongst the radiation sensitive mixture, which graphic pattern has a graphic pattern colour substantially identical to either the first colour or the second colour.
-
公开(公告)号:DK0555205T3
公开(公告)日:2001-03-05
申请号:DK90903253
申请日:1990-01-30
Applicant: RUBIN JEFFREY S , FINCH PAUL W , AARONSON STUART A
Inventor: RUBIN JEFFREY S , FINCH PAUL W , AARONSON STUART A
IPC: A61K39/395 , A61K38/00 , A61K38/18 , A61K38/22 , A61P17/02 , A61P43/00 , C07H21/04 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/47 , C07K14/475 , C07K14/485 , C07K14/50 , C07K16/00 , C07K16/22 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/08 , C12N5/10 , C12N15/09 , C12N15/12 , C12N15/18 , C12N15/63 , C12N15/70 , C12N15/79 , C12P21/00 , C12P21/02 , C12Q1/68 , C12Q1/6876 , C12R1/91 , G01N33/48 , G01N33/50 , G01N33/53 , C07K1/22 , C07K7/06 , C07K7/08 , C07K7/10 , C07K13/00 , C12N5/00 , C12N15/00 , G01N33/536
Abstract: Discoveries are disclosed that show particular aspect or recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as product of antibodies. Means are described fro determining the level of expression of genes for the KGF protein, for example by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
-
公开(公告)号:GB0029598D0
公开(公告)日:2001-01-17
申请号:GB0029598
申请日:2000-12-05
Applicant: GIFFORD LORNE C , HOGG STUART A
-
公开(公告)号:AU3242600A
公开(公告)日:2000-09-14
申请号:AU3242600
申请日:2000-02-23
Applicant: STUART A FOX
Inventor: FOX STUART A
Abstract: A system and method for securely and flexibly handling prepaid card transactions in a single store, chain of stores, or multiple independent stores or chains of stores. Point of sale terminals are programmed to read prepaid cards and contact a host computer that autorizes transactions. The host computer (6) accesses a database containing a list of all clerks authorized to use each terminal. In a preferred embodiment, three types of terminals are provided: activation terminals (3) that permit value to be added to prepaid card, clerk terminals (4) that permit value to be redeemed from, but not added to, prepaid cards, and manager terminals (2) that are capable of adding or deleting a clerk from the list of clerks authorized to use a terminal. The system also permits a merchant or customer service provider to directly access the data base from a computer in a secure restricted manner.
-
公开(公告)号:NO308310B1
公开(公告)日:2000-08-28
申请号:NO972617
申请日:1997-06-06
Applicant: RUBIN JEFFREY S , FINCH PAUL W , AARONSON STUART A
Inventor: RUBIN JEFFREY S , FINCH PAUL W , AARONSON STUART A
IPC: A61K39/395 , A61K38/00 , A61K38/18 , A61K38/22 , A61P17/02 , A61P43/00 , C07H21/04 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/47 , C07K14/475 , C07K14/485 , C07K14/50 , C07K16/00 , C07K16/22 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/08 , C12N5/10 , C12N15/09 , C12N15/12 , C12N15/18 , C12N15/63 , C12N15/70 , C12N15/79 , C12P21/00 , C12P21/02 , C12Q1/68 , C12Q1/6876 , C12R1/91 , G01N33/48 , G01N33/50 , G01N33/53 , G01N33/68 , G01N33/536
Abstract: Discoveries are disclosed that show particular aspect or recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as product of antibodies. Means are described fro determining the level of expression of genes for the KGF protein, for example by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
-
-
-
-
-
-
-
-
-